Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals
March 08, 2017
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it completed the sale to Ferring International...
From
GlobeNewswire News Releases
Lower close ahead of inauguration
January 19, 2017
The markets closed lower with the Dow dropping 72 points to 19,732 ahead of the presidential inauguration tomorrow. Nasdaq fell 15 points to 5,540.
Tags
Market News
From
MarketMinute.com Market Updates
Lower close ahead of inauguration
January 19, 2017
The markets closed lower with the Dow dropping 72 points to 19,732 ahead of the presidential inauguration tomorrow. Nasdaq fell 15 points to 5,540.
Tags
Market News
From
MarketMinute.com Market Updates
15 Biggest Mid-Day Losers For Thursday
January 19, 2017
DryShips Inc. (NASDAQ: DRYS) shares dipped 27.7 percent to $1.15. DryShips reported a 1-for-8 reverse stock ...
Tags
SSH
X
VNOM
From
Benzinga
Market approval in Mexico granted to Apricus Biosciences
January 18, 2017
Mexico granted market approval to Apricus Biosciences Inc.'s (Nasdaq: APRI) erectile dysfunction treatment Vitaros sending the stock price soaring $1.35 to close at $2.86....
From
MarketMinute.com Stock News
Mid-Afternoon Market Update: Crude Oil Down 2.5%; Gigamon Shares Drop After Issuing Lower Forecast
January 18, 2017
Toward the end of trading Wednesday, the Dow traded down 0.18 percent to 19,791.90 while the NASDAQ gained 0.06 percent to 5,542.15. ...
Tags
Movers
PSO
Eurozone
From
Benzinga
Apricus Biosciences Inc (APRI) Stock Scores Win on Vitaros Approval
January 18, 2017
Tags
NASDAQ:APRI
Market Insight, Financial Articles
From
InvestorPlace
15 Biggest Mid-Day Gainers For Wednesday
January 18, 2017
Apricus Biosciences Inc (NASDAQ: APRI) shares jumped 92.7 percent to $2.89 after the company reported the approval of Vitaros in ...
Tags
LIFE
GLBS
APOP
From
Benzinga
Mid-Day Market Update: CoLucid Jumps On Acquisition News; Pearson Shares Tumble
January 18, 2017
Midway through trading Wednesday, the Dow traded down 0.04 percent to 19,818.57 while the NASDAQ gained 0.12 percent to 5,545.18. The ...
Tags
Guidance
Markets
CCJ
From
Benzinga
Mid-Morning Market Update: Markets Mixed; Goldman Sachs Profit Beats Views
January 18, 2017
Following the market opening Wednesday, the Dow traded down 0.11 percent to 19,804.87 while the NASDAQ gained 0.23 percent to ...
Tags
GS
M&A
Benzinga
From
Benzinga
Mixed open as CPI edges up
January 18, 2017
The markets opened mixed with the Dow falling 33 points to 19,793 while Nasdaq rose 14 points to 5,553 as the consumer price index edged up 0.3% in December.
Tags
Market News
From
MarketMinute.com Market Updates
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
January 06, 2017
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
From
Business Wire News Releases
Randy Berholtz Appointed to Hispanica International Delights of America, Inc. Board of Directors
January 06, 2017
From
GlobeNewswire News Releases
Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel
January 02, 2017
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Mary Naggs has been promoted to Vice President,...
From
GlobeNewswire News Releases
Markets soar ahead of Fed rate decision
December 13, 2016
The markets soared to close sharply higher with the Dow surging 114 points to 19,911 even as the Federal Reserve is expected to raise interest rates tomorrow. Nasdaq climbed 51 points to 5,463.
Tags
Market News
From
MarketMinute.com Market Updates
18 Biggest Mid-Day Losers For Friday
November 18, 2016
Wins Finance Holdings Inc (NASDAQ: WINS) shares tumbled 43.8 percent to $80.00. Wins Finance shares have jumped ...
Tags
ASYS
VRTV
MTL
From
Benzinga
Mid-Morning Market Update: Markets Mostly Flat; Foot Locker Profit Beats Estimates
November 18, 2016
Following the market opening Friday, the Dow traded up 0.03 percent to 18,909.00 while the NASDAQ gained 0.03 percent ...
Tags
Commodities
ANF
Eurozone
From
Benzinga
Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results
November 08, 2016
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the third quarter of 2016 and...
From
GlobeNewswire News Releases
18 Biggest Mid-Day Losers For Wednesday
November 02, 2016
Adeptus Health Inc (NYSE: ADPT) shares declined 66 percent to $9.15 after the company posted downbeat quarterly ...
Tags
ADPT
CEMP
PAYC
From
Benzinga
Stocks Hitting 52-Week Lows
November 02, 2016
Apricus Biosciences Inc (NASDAQ: APRI) shares fell 10.7 percent to touch a new 52-week low of $1.67. Apricus ...
Tags
Intraday Update
Markets
MYGN
From
Benzinga
Drug Makers Stocks Under Scanner -- Pernix Therapeutics, Novo Nordisk, Synergy Pharma, and Apricus Biosciences
November 01, 2016
From
PR Newswire
BRIEF-Apricus Biosciences announces 1-for-10 reverse stock split
October 20, 2016
* Apricus Biosciences Inc - reverse stock split will be effective at 5:00 p.m. Pacific time on October 21, 2016 Source text for Eikon: Further company coverage: ;))
Tags
companyNews
From
Reuters: Company News
Apricus Biosciences Announces 1-for-10 Reverse Stock Split
October 20, 2016
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced a reverse stock split of its shares of common stock at a...
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the 2016 BIO Investor Forum
October 12, 2016
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will...
From
GlobeNewswire News Releases
BRIEF-Anson Funds Management LP reports a passive stake of 7 percent in Apricus Biosciences
October 06, 2016
* Anson Funds Management LP reports a passive stake of percent in Apricus Biosciences Inc as of September 28, 2016 - SEC filing Source text for Eikon: Further company coverage:
Tags
companyNews
From
Reuters: Company News
Apricus Biosciences Closes $3.7 Million Registered Direct Offering
September 28, 2016
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has closed a registered direct offering of...
From
GlobeNewswire News Releases
BRIEF-Apricus Biosciences and certain investors mutually agreed to terminate certain securities purchase agreement
September 28, 2016
* On Sept 27, co and certain investors mutually agreed to terminate certain securities purchase agreement, dated Sept 22
Tags
companyNews
From
Reuters: Company News
BRIEF-Apricus Biosciences to issue about 13.1 mln shares at $0.35 per share
September 23, 2016
* Apricus Biosciences announces $4.6 million registered direct offering
Tags
companyNews
From
Reuters: Company News
Apricus Biosciences Announces $4.6 Million Registered Direct Offering
September 23, 2016
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into a definitive agreement with...
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
September 21, 2016
Continued Commercial Expansion in Europe Expected to Increase Royalty Revenue for Apricus
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.